{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:19:04Z","timestamp":1794435544942,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FAPESP: Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o PauloCNPq: Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"},{"name":"Pfizer\/Wyeth, Investigator Sponsored Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Carbapenem-resistant <jats:italic>Klebsiella pneumoniae<\/jats:italic> (CRKP) are highly disseminated worldwide, and isolates co-resistant to other antimicrobial agents pose a threat to effective antimicrobial therapy. Therefore, evaluation of novel antimicrobial drugs is needed to identify potential treatments with better outcomes. We evaluated the in vitro activity of novel antimicrobial drugs\/combinations against 97 KPC-producing <jats:italic>Klebsiella pneumoniae<\/jats:italic> isolates recovered from different hospitals in Brazil during 2021\u20132022. Clonality, resistance and virulence genes were detected by whole-genome sequencing. The majority of the isolates (54.6%) were classified as extensively drug resistant or multidrug resistant (44.3%); one isolate showed a pandrug resistance phenotype. The most active antimicrobial agents were meropenem-vaborbactam, cefiderocol, and ceftazidime-avibactam, with sensitivities higher than 90%; resistance to ceftazidime-avibactam was associated with KPC-33 or KPC-44 variants. Colistin and polymyxin B were active against 58.6% of the isolates. The 97 isolates were distributed into 17 different sequence types, with a predominance of ST11 (37.4%). Although high in vitro susceptibility rates were detected for meropenem-vaborbactam and cefiderocol, only ceftazidime-avibactam is currently available in Brazil. Our findings showed limited susceptibility to antimicrobial drugs employed for infection treatment of carbapenem-resistant <jats:italic>K. pneumoniae<\/jats:italic>, underscoring the urgent need for stringent policies for antimicrobial stewardship to preserve the activity of such drugs.<\/jats:p>","DOI":"10.1038\/s41598-023-41903-x","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T10:02:48Z","timestamp":1693908168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genomic analysis and antimicrobial activity of \u03b2-lactam\/\u03b2-lactamase inhibitors and other agents against KPC-producing Klebsiella pneumoniae clinical isolates from Brazilian hospitals"],"prefix":"10.1038","volume":"13","author":[{"given":"Carlos Henrique","family":"Camargo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Yaeko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia Rodrigues","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Paulo Vieira","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Smith Pereira","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Tavares","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon Benedito","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline Rodrigues","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique Ribeiro","family":"Tiba-Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristela Pinheiro","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqual","family":"Barretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"41903_CR1","unstructured":"W. H. Organization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. (2017)."},{"key":"41903_CR2","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control and Prevention, Prevention, U. S. C. for D. C. and & (CDC), C. for D. C. and P. Antibiotic resistance threats in the United States. U.S Dep. Heal. Hum. Serv. 1\u2013113. https:\/\/doi.org\/10.15620\/CDC:82532 (2013).","DOI":"10.15620\/CDC:82532"},{"key":"41903_CR3","doi-asserted-by":"publisher","first-page":"e0047","DOI":"10.1128\/CMR.00047-19","volume":"33","author":"K Bush","year":"2020","unstructured":"Bush, K. & Bradford, P. A. Epidemiology of \u03b2-lactamase-producing pathogens. Clin. Microbiol. Rev. 33, e0047 (2020).","journal-title":"Clin. Microbiol. Rev."},{"key":"41903_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-021-00931-w","volume":"10","author":"K Iskandar","year":"2021","unstructured":"Iskandar, K. et al. Surveillance of antimicrobial resistance in low- and middle-income countries: A scattered picture. Antimicrob. Resist. Infect. Control 10, 1\u201319 (2021).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"41903_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jhin.2017.03.024","volume":"96","author":"CMCB Fortaleza","year":"2017","unstructured":"Fortaleza, C. M. C. B. et al. Multi-state survey of healthcare-associated infections in acute care hospitals in Brazil. J. Hosp. Infect. 96, 139\u2013144 (2017).","journal-title":"J. Hosp. Infect."},{"key":"41903_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/cid\/cir120","volume":"52","author":"F Rossi","year":"2011","unstructured":"Rossi, F. The challenges of antimicrobial resistance in Brazil. Clin. Infect. Dis. 52, 1138\u20131143 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"41903_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bjm.2016.10.002","volume":"47","author":"JLM Sampaio","year":"2016","unstructured":"Sampaio, J. L. M. & Gales, A. C. Antimicrobial resistance in Enterobacteriaceae in Brazil: Focus on \u03b2-lactams and polymyxins. Braz. J. Microbiol. 47, 31\u201337 (2016).","journal-title":"Braz. J. Microbiol."},{"key":"41903_CR8","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3201\/eid2210.160695","volume":"22","author":"F Bartolleti","year":"2016","unstructured":"Bartolleti, F. et al. Polymyxin B resistance in carbapenem-resistant Klebsiella pneumoniae, S\u00e3o Paulo, Brazil. Emerg. Infect. Dis. 22, 1849\u20131851 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"41903_CR9","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1590\/0037-8682-0861-2020","volume":"54","author":"LB Pereira","year":"2021","unstructured":"Pereira, L. B. et al. Antibiotic use in Brazilian hospitals in the 21st century: A systematic review. Rev. Soc. Bras. Med. Trop. 54, 2021 (2021).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"41903_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40121-020-00395-2","volume":"10","author":"GT Hansen","year":"2021","unstructured":"Hansen, G. T. Continuous evolution: Perspective on the epidemiology of carbapenemase resistance among Enterobacterales and other Gram-negative bacteria. Infect. Dis. Ther. 10, 75\u201392 (2021).","journal-title":"Infect. Dis. Ther."},{"key":"41903_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bjid.2016.09.011","volume":"21","author":"F Rossi","year":"2017","unstructured":"Rossi, F. et al. Emergence of colistin resistance in the largest university hospital complex of S\u00e3o Paulo, Brazil, over five years. Braz. J. Infect. Dis. 21, 98\u2013101 (2017).","journal-title":"Braz. J. Infect. Dis."},{"key":"41903_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"41903_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105883","volume":"55","author":"SC Kuo","year":"2020","unstructured":"Kuo, S. C. et al. Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015\u20132016. Int. J. Antimicrob. Agents 55, 105883 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"41903_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268\u2013281 (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"41903_CR15","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3201\/eid2606.191517","volume":"26","author":"RA Bonnin","year":"2020","unstructured":"Bonnin, R. A. et al. Emergence of new non-clonal group 258 high-risk clones among Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates, France. Emerg. Infect. Dis. 26, 1212\u20131220 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"41903_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3201\/eid1609.091389","volume":"16","author":"G Cuzon","year":"2010","unstructured":"Cuzon, G. et al. Worldwide diversity of Klebsiella pneumoniae that produces \u03b2-lactamase blaKPC-2 Gene. Emerg. Infect. Dis. 16, 1349\u20131356 (2010).","journal-title":"Emerg. Infect. Dis."},{"key":"41903_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41579-019-0315-1","volume":"18","author":"KL Wyres","year":"2020","unstructured":"Wyres, K. L., Lam, M. M. C. & Holt, K. E. Population genomics of Klebsiella pneumoniae. Nat. Rev. Microbiol. 18, 344\u2013359 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"41903_CR18","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1128\/AAC.01783-10","volume":"55","author":"LN Andrade","year":"2011","unstructured":"Andrade, L. N. et al. Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL\/M) among Enterobacteriaceae species in Brazil. Antimicrob. Agents Chemother. 55, 3579\u20133583 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41903_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/pathogens10030332","volume":"10","author":"LB Migliorini","year":"2021","unstructured":"Migliorini, L. B. et al. Prevalence of blaKPC-2, blaKPC-3 and blaKPC-30\u2014Carrying plasmids in Klebsiella pneumoniae isolated in a Brazilian hospital. Pathogens 10, 332 (2021).","journal-title":"Pathogens"},{"key":"41903_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel, L., Jayol, A. & Nordmann, P. Polymyxins: Antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin. Microbiol. Rev. 30, 557\u2013596 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"41903_CR21","doi-asserted-by":"crossref","unstructured":"Paul, M. et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine). Clin. Microbiol. Infect. 28, 521\u2013547 (Elsevier, 2022).","DOI":"10.1016\/j.cmi.2021.11.025"},{"key":"41903_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jhin.2019.10.016","volume":"104","author":"APM Porto","year":"2020","unstructured":"Porto, A. P. M., Goossens, H., Versporten, A. & Costa, S. F. Global point prevalence survey of antimicrobial consumption in Brazilian hospitals. J. Hosp. Infect. 104, 165\u2013171 (2020).","journal-title":"J. Hosp. Infect."},{"key":"41903_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10096-020-04000-9","volume":"40","author":"I Galani","year":"2021","unstructured":"Galani, I. et al. Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment. Eur. J. Clin. Microbiol. Infect. Dis. 40, 219\u2013224 (2021).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"41903_CR24","doi-asserted-by":"publisher","first-page":"57421","DOI":"10.1128\/AAC.00574-21","volume":"65","author":"A Carattoli","year":"2021","unstructured":"Carattoli, A. et al. Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates. Antimicrob. Agents Chemother. 65, 57421 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41903_CR25","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.2147\/IDR.S371285","volume":"15","author":"M Jiang","year":"2022","unstructured":"Jiang, M. et al. Diversity of ceftazidime-avibactam resistance mechanism in KPC2-producing Klebsiella pneumoniae under antibiotic selection pressure. Infect. Drug Resist. 15, 4627\u20134636 (2022).","journal-title":"Infect. Drug Resist."},{"key":"41903_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jgar.2021.04.001","volume":"25","author":"S Di Bella","year":"2021","unstructured":"Di Bella, S. et al. Resistance to ceftazidime\/avibactam in infections and colonisations by KPC-producing Enterobacterales: A systematic review of observational clinical studies. J. Glob. Antimicrob. Resist. 25, 268\u2013281 (2021).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"41903_CR27","doi-asserted-by":"publisher","first-page":"741940","DOI":"10.3389\/fmed.2021.741940","volume":"8","author":"J Yao","year":"2021","unstructured":"Yao, J., Wang, J., Chen, M. & Cai, Y. Cefiderocol: An overview of its in-vitro and in-vivo activity and underlying resistant mechanisms. Front. Med. 8, 741940 (2021).","journal-title":"Front. Med."},{"key":"41903_CR28","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1128\/AAC.01694-17","volume":"61","author":"D Sun","year":"2017","unstructured":"Sun, D., Rubio-Aparicio, D., Nelson, K., Dudley, M. N. & Lomovskaya, O. Meropenem-vaborbactam resistance selection, resistance prevention, and molecular mechanisms in mutants of KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 61, 1694 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41903_CR29","doi-asserted-by":"publisher","first-page":"139022","DOI":"10.1128\/spectrum.01390-22","volume":"10","author":"C Xu","year":"2022","unstructured":"Xu, C. et al. Development of resistance to eravacycline by Klebsiella pneumoniae and collateral sensitivity-guided design of combination therapies. Microbiol. Spectr. 10, 139022 (2022).","journal-title":"Microbiol. Spectr."},{"key":"41903_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/antibiotics11060723","volume":"11","author":"S Karakonstantis","year":"2022","unstructured":"Karakonstantis, S., Rousaki, M. & Kritsotakis, E. I. Cefiderocol: Systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiotics 11, 723 (2022).","journal-title":"Antibiotics"},{"key":"41903_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fcimb.2022.898125","volume":"12","author":"OC Concei\u00e7\u00e3o-Neto","year":"2022","unstructured":"Concei\u00e7\u00e3o-Neto, O. C. et al. Polymyxin resistance in clinical isolates of K. pneumoniae in Brazil: Update on molecular mechanisms, clonal dissemination and relationship with KPC-producing strains. Front. Cell Infect. Microbiol. 12, 1012 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"41903_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.12.009","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Wang, J., Wang, R. & Cai, Y. Resistance to ceftazidime-avibactam and underlying mechanisms. J. Glob. Antimicrob. Resist. https:\/\/doi.org\/10.1016\/j.jgar.2019.12.009 (2019).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"41903_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel, L., Walsh, T. R., Cuvillier, V. & Nordmann, P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70, 119\u2013123 (2011).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"41903_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/fpd.2006.3.59","volume":"3","author":"EM Ribot","year":"2006","unstructured":"Ribot, E. M. et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3, 59\u201367 (2006).","journal-title":"Foodborne Pathog. Dis."},{"key":"41903_CR35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/nar\/gkac247","volume":"50","author":"E Afgan","year":"2022","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 50, 345 (2022).","journal-title":"Nucleic Acids Res."},{"key":"41903_CR36","first-page":"33","volume":"1","author":"L Chen","year":"2005","unstructured":"Chen, L. et al. VFDB: A reference database for bacterial virulence factors. Nucleic Acids Res. 1, 33 (2005).","journal-title":"Nucleic Acids Res."},{"key":"41903_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-17996-1","volume":"12","author":"A Spadar","year":"2022","unstructured":"Spadar, A. et al. Genomic epidemiological analysis of Klebsiella pneumoniae from Portuguese hospitals reveals insights into circulating antimicrobial resistance. Sci. Rep. 12, 1\u201313 (2022).","journal-title":"Sci. Rep."},{"key":"41903_CR38","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/bioinformatics\/btv421","volume":"31","author":"AJ Page","year":"2015","unstructured":"Page, A. J. et al. Roary: Rapid large-scale prokaryote pan genome analysis. Bioinformatics 31, 3691\u20133693 (2015).","journal-title":"Bioinformatics"},{"key":"41903_CR39","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh, B. Q. et al. IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530\u20131534 (2020).","journal-title":"Mol. Biol. Evol."},{"key":"41903_CR40","doi-asserted-by":"publisher","first-page":"1005595","DOI":"10.1371\/journal.pcbi.1005595","volume":"13","author":"RR Wick","year":"2017","unstructured":"Wick, R. R., Judd, L. M., Gorrie, C. L. & Holt, K. E. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 13, 1005595 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"41903_CR41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41903-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41903-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41903-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T23:13:22Z","timestamp":1700262802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41903-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41903"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41903-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PB has received support for research from Pfizer\/Wyeth. CHC and MRTC has received Productivity Research Fellows from Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq 302543\/2021-0). Remaining authors have declared that no competing interests exist.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14603"}}